HealthEquity Reports First Quarter Ended April 30, 2024 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St hits two-week lows as rising bond yields, Walmart results drag
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Jefferies Reiterates Buy Rating on HealthEquity, Inc (HQY)
June 3, 2024 4:33 PM EDTJefferies analyst Glen Santangelo reiterated a Buy rating and $95.00 price target on HealthEquity, Inc (NASDAQ: HQY)
The analyst comments "HQY reported another exceptional qtr with revs and EBITDA comfortably ahead. The company is executing well, benefitting from strong HSA sales, greater utilization of... More
